Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET
Company Participants
Courtney Solberg - Manager, Corporate Communications and IR
Nancy Simonian - CEO
Jason Haas - CFO
David Roth - Chief Medical Officer
Kristin Stephens - Chief Development Office
Eric Olson - Chief Scientific Officer
Conley Chee - Chief Commercial Officer
Conference Call Participants
Ted Tenthoff - Piper Sandler
Eva Previtera - Cowen
Jason Butler - JMP Securities
Mark Breidenbach - Oppenheimer
Zegbeh Jallah - ROTH Capital Partners
Matthew Cross - Alliance Global Partners
Operator
Good morning and welcome to Syros Pharmaceuticals First Quarter 2022 Financial Results Conference Call.
At this time, all participants are in listen-only mode. This call is being webcast live on the Investors & Media section of Syros’ website at www.syros.com. Please be advised that today's conference is being recorded.
At this time, I would like to turn the call over to Courtney Solberg, Manager of Corporate Communications and Investor Relations at Syros.
Courtney Solberg
Thank you. This morning, we issued a press release announcing our first quarter 2022 financial results and a broader business update. The release is available on Investors & Media section of Syros' website at www.syros.com. We will begin the call with prepared remarks by Dr. Nancy Simonian; our Chief Executive Officer and Jason Haas, our Chief Financial Officer. We will then open the call for questions. Dr. David Roth, our Chief Medical Officer, Kristin Stephens our Chief Development Officer, Dr. Eric Olson, our Chief Scientific Officer and Conley Chee, our Chief Commercial Officer are also on the call and will be available for Q&A.
Before we begin, I would like to remind everyone that statements we make on this call will include forward-looking statements. Actual events or results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors, including those set forth in the Risk Factors section of our annual report on Form 10-K and our quarterly report on Form 10-Q for the first quarter that we filed this morning and any other filings that we make with SEC in the future. Any forward-looking statements made on this call represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. We specifically disclaim any obligation to update or revise any forward-looking statements.